Streetbeat News

Stock Prices

SYM

Symbotic Inc. (NASDAQ:SYM) stock surged in after-hours trading following the release of their Q4 sales results, which exceeded analyst expectations. The company reported a smaller loss per share than anticipated and a significant increase in quarterly sales compared to the same period last year. Symbotic also provided positive guidance for Q1 revenue and adjusted EBITDA. CEO Rick Cohen highlighted the company's growth and plans for continued investment in innovation and partnerships.

Portfolio Pulse from Ryan Gustafson

November 20, 2023 | 10:05 pm

MOR

MorphoSys shares continue to decline after the company released trial results. The specific details of the trial results, such as the nature of the trial, the data outcomes, or the market's reaction, are not provided in the article.

Portfolio Pulse from Charles Gross

November 20, 2023 | 10:03 pm

FSR

Fisker Inc. has received a notice from the NYSE regarding a late filing of its Form 10-Q. The company has six months from November 14, 2023, to file the report with the SEC to regain compliance with NYSE listing standards.

Portfolio Pulse from Benzinga Newsdesk

November 20, 2023 | 10:02 pm

ELUT

Elutia has announced that selling securityholders may offer and sell up to 18.57 million shares of its Class A common stock. This could potentially increase the stock's liquidity and may result in downward pressure on the share price due to the increased supply of shares available in the market.

Portfolio Pulse from Benzinga Newsdesk

November 20, 2023 | 10:01 pm

ARKK

BLK

Bernstein analysts predict Bitcoin's market cap could exceed $3 trillion by mid-2025, citing low churn rates, the upcoming Bitcoin halving, new FASB accounting guidelines, potential approval of a U.S.-listed spot Bitcoin ETF, and its use as a hedge against currency debasement. The SEC is engaging with asset managers like BlackRock and Ark Invest on ETF applications.

Portfolio Pulse from Murtuza Merchant

November 20, 2023 | 9:52 pm

KEYS

Keysight Technologies (NYSE:KEYS) reported Q4 earnings of $1.99 per share, surpassing estimates of $1.87, despite a 7.01% decrease from the previous year. Revenue was $1.31 billion, slightly above the $1.30 billion estimate but down 9.22% from last year. The company's cash flow from operations was $378 million, and free cash flow remained steady at $340 million. KEYS provided Q1 guidance with earnings between $1.53 and $1.59 per share, below the $1.67 estimate, and revenue projections between $1.235 billion and $1.255 billion, around the $1.24 billion estimate. After the report, KEYS shares rose 1.67% to $137.21 in after-hours trading.

Portfolio Pulse from Ryan Gustafson

November 20, 2023 | 9:50 pm

EIS

IZRL

President Biden expressed optimism about a potential hostage deal between Israel and Hamas. Israel proposed a 5-day ceasefire in exchange for 50 hostages, but disagreements persist. UN Secretary-General Guterres expressed concern over civilian killings. Houthi rebels seized an Israeli cargo vessel, the Galaxy Leader, owned by Israeli businessman Abraham Ungar. The U.S. State Department demanded its release. Israeli stocks and ETFs, including iShares MSCI Israel ETF (EIS) and ARK Israel Innovative Technology ETF (IZRL), saw gains.

Portfolio Pulse from Piero Cingari

November 20, 2023 | 9:49 pm

MOR

MorphoSys AG ADS shares are set to resume trading at 5:00 p.m. ET after a halt. There is no additional information provided regarding the reason for the halt or any other factors that might influence the stock price.

Portfolio Pulse from Benzinga Newsdesk

November 20, 2023 | 9:38 pm

KZIA

Kazia Therapeutics Limited (KZIA) received a deficiency notification from Nasdaq for not meeting the minimum bid price requirement. The company's stock price fell below $1.00 for 30 consecutive days. Kazia has until May 20, 2024, to regain compliance by maintaining a bid price of $1.00 or more for 10 consecutive days. The company's securities will continue to trade normally on Nasdaq during this period, and Kazia is looking to resolve the issue to avoid delisting.

Portfolio Pulse from Benzinga Newsdesk

November 20, 2023 | 9:37 pm

CENTA

Central Garden & Pet (NASDAQ:CENTA) reported Q4 earnings with an EPS of $0.1, surpassing the estimate of $0.07 by 42.86%. Revenue increased by $42.70 million compared to the same period last year. Despite beating EPS estimates last quarter, the share price dropped by 0.3% the following day. The company's past earnings performance shows a mixed track record of beating and missing EPS and revenue estimates.

Portfolio Pulse from Benzinga Insights

November 20, 2023 | 9:35 pm